Dyslipidemia in Asian Indians: Determinants and significance

Journal of Association of Physicians of India

Volumn 52, Issue FEB, 2004, Pages 137-142

  Misra, A ^a   Luthra, Kalpana ^a   Vikram, N K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ASIAN; COMPARATIVE STUDY; ETHNOLOGY; FEMALE; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; INCIDENCE; INDIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; REVIEW; RISK ASSESSMENT; SEX RATIO; STATISTICS; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPIDEMIAS; INCIDENCE; INDIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 13744254491     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Richards EG, Grundy SM, Cooper K. Influence of plasma triglycerides on lipoprotein patterns in normal subjects and in patients with coronary artery disease. Am J Cardiol 1989;63:1214-20.
2. Schaefer EJ, Levy RI, Anderson DW, Danner RN, Brewer HB, Jr., Blackwelder WC. Plasma-triglycerides in regulation of HDL-cholesterol levels. Lancet 1978;2:391-3.
3. Blades B, Vega GL, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb 1993;13:1227-35.
4. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97-104.
5. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241-53.
6. Griffin BA, Minihane AM, Furlonger N, et al. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Clin Sci (Lond) 1999;97:269-76.
7. Sattar N, Greer IA, Louden J, et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab 1997;82:2483-91.
8. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998;81:18B-25B.
9. de Graff J, Hak-Lemmers HLM, Hectors PNM, Demacker JCM, Stalenholf AFH. Enhanced susceptibility to invitro oxidation of the dense low density lipoprotein subfractions in healthy subjects. Arterioscler Thromb 1991;11:298-306.
10. Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 1997;5:93-9.
11. Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and adipose tissue depots. Nutrition 2002;19:457-466.
12. Misra A. Body composition and the metabolic syndrome in Asian Indians: a saga of multiple adversities. Natl Med J India 2003;16:3-7.
13. Misra A. Impact of ethnicity on body fat patterning in Asian Indians and Blacks: Relationship with insulin resistance. Nutrition 2003;19:815-6.
14. Misra A. Revision of limits of body mass index to define overweight and obesity are needed for the Asian ethnic groups. Int J Obes and Relat Metab Disord 2003;27:1294-1296.
15. Misra A, Athiko D, Sharma R, Pandey RM, Khanna N. Non-obese hyperlipidemic Asian northern Indian males have adverse anthropometric profile. Nutr Metab Cardiovasc Dis 2002;12:178-83.
16. Misra A, Sharma R, Pandey RM, Khanna N. Adverse profile of dietary nutrients, anthropometry and lipids in urban slum dwellers of northern India. Eur J Clin Nutr 2001;55:727-34.
17. Perseghin G, Scifo P, De Cobelli F, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a IH-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999;48:1600-6.
18. Misra A. Insulin resistance syndrome: current perspective and its relevance in Indians. Indian Heart J 1998;50:385-95.
19. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr Sci 2002;83:1483-96 (available at http://tejas.serc.iisc. ernet.in/~currsci).
20. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: Evidence and implications. Nutrition 2003 (in press).
21. 2) Asian Indians with 'normal' waist circumference have high cardiovascular risk. Nutrition 2003;19:503-9.
22. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601.
23. Reddy KS. Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutr 2002;5:231-7.
24. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
25. Gama R, Elfatih AB, Anderson NR. Ethnic differences in total and HDL cholesterol concentrations:Caucasians compared with predominantly Punjabi Sikh Indo-Asians. Ann Clin Biochem 2002;39(Pt6):609-11.
26. Gupta R, Prakash H, Kaul V. Cholesterol lipoproteins, triglycerides, rural-urban differences and prevalence of dyslipidaemia among males in Rajasthan. J Assoc Physicians India 1997;45:275-9.
27. Gopinath N, Chadha SL, Jain P, Shekhawat S, Tandon R. An epidemiological study of obesity in adults in the urban population of Delhi. J Assoc Physicians India 1994;42:212-5.
28. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK. Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 2001;25:1722-9.
29. Tai ES, Emmanuel SC, Chew SK, Tan BY, Tan CE. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes 1999;48:1088-92.
30. Dhingra V, Chatterjee A, Guleria R, Sharma R, Pandey RM, Talwar KK, Misra A. Adverse physical activity pattern in urban adolescents. J Assoc Physicians India 2002;50:1521.
31. Renges HH, Wile DB, McKeigue PM. Marmot MG, Humphries SE. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent. Atherosclerosis 1991;91:267-75.
32. Saha N, Tay JS, Heng CK, Humphries SE. DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin Genet 1993;44:113-20.
33. Misra A, Nishanth S, Pasha ST. Pandey RM, Sethi P, Rawat DS. Relationship of Xba I and EcoR I polymorphisms of apolipoprotein-B gene to dyslipidemia and obesity in Asian Indians in North India. Indian Heart J 2001;53:177-83.
34. Luthra K, Bharghav B, Chabbra S, et al. Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins. Mol Cell Biochem 2002;232:97-102.
35. Chhabra S, Narang R, Krishnan LR, et al. Apolipoprotein C3 Sstl polymorphism and triglyceride levels in Asian Indians. BMC Genet 2002;3:9.
36. Miller M, Rhyne J, Khatta M, Parekh H, Zeller K. Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian-Indians. Am J Cardiol 2001;87:220-1, A8.
37. A4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
38. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997;17:1114-1120.
39. Abbey M, Clifton P, Kestin M, Belling B, Nestel P. Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 1990;10:85-94.
40. Lungershausen YK, Abbey M, Nestel PJ, Howe PR. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens 1994;12:1041-5.
41. Olsson A, Istad H, Luurila O, et al. Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia. Am Heart J 2002;144:1044-1051.
42. Pontrelli L, Parris W, Adeli K, Cheung RC. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes. Metobolism 2002;51:334-342.
43. Jonkers IJ, Mohrschladt MF, Westendorp RG, van der Laarse A, Smelt AH. Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. Am J Med 2002;112:275-80.
44. Garg A, Grundy S. Nicotinic acid as therapy for dyslipidemia in non-insulin dependent diabetes mellitus. JAMA 1990;264:723-726.
45. Liamis G, Kakafika A, Bairaktari E, et al. Combined treatment - with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia. Curr Med Res Opin 2002;18:125-8.
46. Taher TH, Dzavik V, Reteff EM, Pearson GJ, Woloschuk BL, Francis GA. Tolerability of statin-fibrate and statin-niacin combination therapy in dyslipidemic patients at high risk for cardiovascular events. Am J Cardiol 2002;89:390-394.
47. Wierzbicki AS, Mikhailidis DP, Wray R, et al. Statin-fibrate combination: therapy, for hyperlipidemia: a review. Curr Med Res Opin 2003;19:155-168.
48. Vikram NK, Misra A, Dwivedi M, et al. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 2003;168:305-13.
49. Goyal P, Sharma G, Bal BS, et al. Prospective, noninterventional, uncontrolled, open-chart, pharmacoepidemiologic study of prescribing patterns for lipid-lowering drugs at a tertiary care teaching hospital in North India. Clin Ther 2002;24:2064-76.
50. Chadha SL, Gopinath N, Shekhawat S. Urban-rural differences in the prevalence of coronary heart disease and its risk factors in Delhi. Bull World Health Organ 1997;75:31-8.
51. Reddy KS. Primordial prevention of coronary heart disease in India: challenges and opportunities. Prey Med 1999;29:S119-23.
52. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6.
53. Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health 1997;51:394-9.
54. Tan CE, Emmanuel SC, Tan BY, Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 1999;22:241-7.
55. Patel S, Unwin N, Bhopal R, et al. A comparision of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diab Med 1999;16:853-860.
56. Deurenberg-Yap M, Chew SK, Lin VF, Tan BY, van Staveren WA, Deurenberg P. Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore. Int J Obes Relat Metab Disord 2001;25:1554-62.
57. Lubree HG, Rege SS, Bhat DS, et al. Body fat and cardiovascular risk factors in Indian men in three geographical locations. Food Nutr Bull 2002;23:146-9.